Show simple item record

Molekulsko modelovanje i analiza 3D-strukture farmakofore selektivnih PI3K-α inhibitora kao antitumorskih agenasa

dc.creatorJovanović, Milan
dc.creatorNikolić, Katarina
dc.creatorGagić, Žarko
dc.creatorAgbaba, Danica
dc.date.accessioned2019-09-02T12:04:46Z
dc.date.available2019-09-02T12:04:46Z
dc.date.issued2018
dc.identifier.issn0004-1963
dc.identifier.urihttp://farfar.pharmacy.bg.ac.rs/handle/123456789/3099
dc.description.abstractThe importance of the activation of phosphatidylinositol-3-kinase (PI3K) in the processes of tumor cell formation and growth has brought great interest in the development of new antitumor drugs that inhibit the PI3K-Akt signaling pathway. Recent studies have shown that in most tumors the activity of p110α isoform of PI3K kinase has been altered, and today special emphasis is placed on developing specific PI3K-α inhibitors. In a series of 92 PI3K-α inhibitors, whose data on experimentally determined inhibitory activity were collected from literature, 3D quantitative structure-activity relationship studies (3D-QSAR) were carried out. All molecular structures were previously optimized using semiempirical PM3 and ab initio Hartree-Fock / 3- 21G methods, and modeling was performed using PLS regression analysis. Calculated parameters of internal (R2=0.84; Q2=0.67) and external (R2pred=0.681; r2m=0.594; Δr2m=0.00039)validation indicate on good reliability and predictive power of created 3D-QSAR model. The analysis of the variables enabled pharmacophore structure determination, which implies: presence of hydrogen bond donor and hydrogen bond acceptor at a distance of 18-18.4Å or 12- 12.4Å, presence of hydrophobic domain and hydrogen bond donor at a distance of 15.2-15.6Å, and presence of steric hotspot at optimal distance from hydrogen bond donor and acceptor. These results will have the relevance in selecting the lead compounds for targeted structural modifications in order to design new selective PI3K-α inhibitors as potential antitumor drugs.en
dc.description.abstractZnačaj aktivacije fosfatidilinozitol-3-kinaza (PI3K) u procesima nastanka i rasta ćelija karcinoma doveo je do velikog interesovanja za razvijanje novih antitumorskih lekova koji inhibiraju PI3K-Akt signalni put. Najnovija istraživanja pokazuju da je kod većine tipova karcinoma izmenjena aktivnost p110α izoforme PI3K kinaze, te se danas poseban akcenat stavlja na razvijanje specifičnih PI3K-α inhibitora. Na seriji od 92 PI3K-α inhibitora, čiji su podaci o eksperimentalno određenoj inhibitornoj aktivnosti prikupljeni iz literature, sprovedene su 3D studije kvantitativnog odnosa između strukture i dejstva (3D-QSAR). Sve molekulske strukture su prethodno optimizovane upotrebom semiempirijske PM3 i ab initio Hartree-Fock/3-21G metode, a modelovanje je vršeno primenom PLS regresione analize najmanjih kvadrata. Izračunati parametri interne (R2=0,84; Q2=0,67) i eksterne (R2pred=0,681; r2m=0,594; Δr2m=0,00039) validacije ukazuju na pouzdanost i dobru moć predviđanja formiranog 3DQSAR modela. Analizom varijabli određena je struktura farmakofore koja podrazumeva: prisustvo donora i akceptora vodonične veze na rastojanju 18-18,4 Å ili 12-12,4 Å; hidrofobni region na rastojanju od 15,2-15,6 Å od donora vodonične veze kao i prisustvo sternog centra na optimalnom rastojanju od donora i akceptora vodonične veze. Ovi rezultati će imati značaj u odabiru vodećih jedinjenja na kojima će biti moguće vršiti ciljane strukturne modifikacije za dizajniranje novih selektivnih PI3K-α inhibitora kao potencijalnih antineoplastika.sr
dc.publisherSavez farmaceutskih udruženja Srbije, Beograd
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172033/RS//
dc.rightsopenAccess
dc.sourceArhiv za farmaciju
dc.subject3D-QSARen
dc.subjectpharmacophoreen
dc.subjectPI3K-αen
dc.subjectinhibitoren
dc.subjecttumoren
dc.subject3D-QSARsr
dc.subjectfarmakoforasr
dc.subjectPI3K-αsr
dc.subjectinhibitorsr
dc.subjecttumorsr
dc.titleMolecular modeling and analysis of the 3D pharmacophore structure of the selective PI3K-α inhibitors as antitumor agentsen
dc.titleMolekulsko modelovanje i analiza 3D-strukture farmakofore selektivnih PI3K-α inhibitora kao antitumorskih agenasasr
dc.typearticle
dc.rights.licenseBY-SA
dcterms.abstractНиколић, Катарина; Aгбаба, Даница; Јовановић, Милан; Гагић, Жарко; Молекулско моделовање и анализа 3Д-структуре фармакофоре селективних ПИ3К-α инхибитора као антитуморских агенаса; Молекулско моделовање и анализа 3Д-структуре фармакофоре селективних ПИ3К-α инхибитора као антитуморских агенаса;
dc.citation.volume68
dc.citation.issue4
dc.citation.spage860
dc.citation.epage873
dc.citation.other68(4): 860-873
dc.citation.rankM52
dc.identifier.doi10.5937/ArhFarm1804860J
dc.identifier.scopus2-s2.0-85064731440
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs//bitstream/id/1695/3097.pdf
dc.identifier.rcubconv_593
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record